Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
127
datasets available to search
ShareScore release 0.9.0
Dataset results
127 results for “biomarker discovery”
Pulse Biomarker Discovery
ClinicalTrials.gov study NCT04887584. IPD Sharing: NO. Countries: 1. Publications: 20.
Discovery of New Circulating Biomarkers of Coronary Atherosclerosis
ClinicalTrials.gov study NCT00430820. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Biomarker Discovery and Validation in Lung Cancer
ClinicalTrials.gov study NCT01147562. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Genetic Biomarker Discovery for Metastatic Prostate Cancer
ClinicalTrials.gov study NCT03228810. IPD Sharing: NO. Countries: 1. Publications: 1.
Salivary Biomarker Discovery by Raman Spectroscopy in ALS (SalivALS)
ClinicalTrials.gov study NCT04233099. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Discovery of New Early Detection Biomarkers of Acute Respiratory Distress Syndrome
ClinicalTrials.gov study NCT02625064. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease
ClinicalTrials.gov study NCT03136679. IPD Sharing: NO. Countries: 1. Publications: 3.
Discovery of Biomarkers of Intake of of Highly Consumed Foods in Mexico
ClinicalTrials.gov study NCT06449170. IPD Sharing: Not stated. Countries: 1. Publications: 27.
Data from: Profiling extracellular long RNA transcriptome in human plasma and extracellular vesicles for biomarker discovery
Open the record for dataset details and reuse information.
How to commercialize your biomarker discovery - Free web seminar #1
<p>During this first web seminar the <strong>BIC - Biomarker Commercialization</strong> project presents a new toolset for biomarker development and commercialization - the BIC Guide.</p> <p>The biomarker commercialization guide covers technical, clinical, commercial and regulatory aspects, and it is designed to support, step-by-step, both academic researchers and SMEs when developing a biomarker-based invention to a commercial product. Other tools created during the project will be a Best Practices Handbook based on experiences from TTOs in the field, and a review tool for TTOs and a guide for regulatory process. The toolset has been created in the BIC project funded by Interreg Baltic Sea Region Programme, and it will be available for free in summer 2020.</p> <p><strong>Key Topics:</strong></p> <ul> <li><strong>BIC Guide: a set of tools for supporting Biomarker Commercialization </strong>(Valerie Daussin, Project Leader for the BIC consortium, University Hospital of Aalborg) - Presentation available for download</li> <li><strong>SME experience with BIC Guide </strong>(Huram Konjen, CEO of Dianox)</li> </ul> <p><strong>Moderator:</strong> Teppo Laaksonen, Network Manager, Turku Science Park Ltd</p>
Data from: Discovery of metabolic biomarkers for Duchenne Muscular Dystrophy within a natural history study
Serum metabolite profiling in Duchenne muscular dystrophy (DMD) may enable discovery of valuable molecular markers for disease progression and treatment response. Serum samples from 51 DMD patients from a natural history study and 22 age-matched healthy volunteers were profiled using liquid chromatography coupled to mass spectrometry (LC-MS) for discovery of novel circulating serum metabolites associated with DMD. Fourteen metabolites were found significantly altered (1% false discovery rate) in their levels between DMD patients and healthy controls while adjusting for age and study site and allowing for an interaction between disease status and age. Increased metabolites included arginine, creatine and unknown compounds at m/z of 357 and 312 while decreased metabolites included creatinine, androgen derivatives and other unknown yet to be identified compounds. Furthermore, the creatine to creatinine ratio is significantly associated with disease progression in DMD patients. This ratio sharply increased with age in DMD patients while it decreased with age in healthy controls. Overall, this study yielded promising metabolic signatures that could prove useful to monitor DMD disease progression and response to therapies in the future.
Single cell spatial analysis and biomarker discovery in Hodgkin lymphoma
<p>Imaging Mass Cytometry Data of Hodgkin Lymphoma. Details in associated manuscript</p>
Discovery of Sirolimus Sensitive Biomarkers in Blood
ClinicalTrials.gov study NCT03304678. IPD Sharing: YES. Countries: 1. Publications: 0.
Discovery of Novel Biomarkers of Dietary Exposure in the EPIC Calibration Study
ClinicalTrials.gov study NCT03683654. IPD Sharing: UNDECIDED. Countries: 0. Publications: 3.
Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma
ClinicalTrials.gov study NCT02487394. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Data from: Discovery of metabolic biomarkers for Duchenne Muscular Dystrophy within a natural history study
Open the record for dataset details and reuse information.
Overcoming intra-tumoral heterogeneity for biomarker discovery in the High-Grade Serous Ovarian Cancer proteome
GEO Series GSE277107. Homo sapiens. 22 samples. Type: Expression profiling by high throughput sequencing.
Biomarker Discovery in Attention Deficit Hyperactivity Disorder: RNA sequencing of Whole Blood in Discordant Twin and Case-Controlled Cohorts
GEO Series GSE159104. Homo sapiens. 154 samples. Type: Expression profiling by genome tiling array.
Discovery of lncRNA biomarkers of prostate cancer
GEO Series GSE115414. Homo sapiens. 24 samples. Type: Expression profiling by high throughput sequencing.
Discovery of Methylated Circulating DNA Biomarkers For Comprehensive Non-Invasive Monitoring Of Treatment Response In Metastatic Colorectal Cancer.
GEO Series GSE86078. Homo sapiens. 149 samples. Type: Methylation profiling by genome tiling array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.